Demise of Polymerase Chain Reaction/Electrospray Ionization-Mass Spectrometry as an Infectious Diseases Diagnostic Tool
Clicks: 180
ID: 117153
2018
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.7
/100
9 views
9 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
PCR/electrospray ionization-mass spectrometry had been under development for over a decade. It had become commercially available in Europe in 2014 and was under
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (23 words).
Try re-searching for a better abstract.
| Reference Key |
volkan2018clinicaldemise
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Özenci, Volkan;Patel, Robin;Ullberg, Måns;Strålin, Kristoffer; |
| Journal | clinical infectious diseases |
| Year | 2018 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
United States
united states food and drug administration
polymerase chain reaction*
bacteremia / diagnosis
kristoffer strålin
communicable diseases / diagnosis*
robin patel
spectrometry
sepsis / diagnosis
mass
pmid:29020209
doi:10.1093/cid/cix743
volkan Özenci
molecular diagnostic techniques / standards
electrospray ionization*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.